Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Franzen
Pdb110 - Treatment Persistence in Patients With Type 2 Diabetes Treated With GLP-1 Receptor Agonists in Clinical Practice in Sweden: Nationwide Retrospective Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Spin-Dependent Mechanism for Diatomic Ligand Binding to Heme
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Pdb68 - Cost-Effectiveness Analysis of Exenatide Versus GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb112 - Treatment and Dosing Patterns Among Patients With Type 2 Diabetes (T2d) Initiating Glucagon-Like Peptide-1 Receptor Agonists (Glp-1 Ras) in Several Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Thyroid Disease in Insulin-Treated Patients With Type 2 Diabetes: A Retrospective Study
Thyroid Research
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Clinical Characteristics in Patients With Type 2 Diabetes Mellitus: A Cohort Study
Endocrine Abstracts
Higher Risk of Thyroid Disorders in Young Patients With Type 1 Diabetes: A 12-Year Nationwide, Population-Based, Retrospective Cohort Study
PLoS ONE
Multidisciplinary
Increased Risk of Cancer in Patients With Type 2 Diabetes Mellitus: A Retrospective Cohort Study in China
BMC Public Health
Environmental
Public Health
Occupational Health
Evaluating Preferences for Profiles of GLP-1 Receptor Agonists Among Injection-Naïve Type 2 Diabetes Patients in the UK
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes
Clinical Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients
Drugs in Context
Molecular Medicine
Pharmacology
